Select Medical Holdings Corporation (SEM) — Financial statements
Income statement, balance sheet, and cash flow for Select Medical Holdings Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 5,453↑5.1% | 5,187↓22.2% | 6,664↑5.2% | 6,334↑2.1% | 6,205 | |
| Cost of Revenue | 4,824↑5.9% | 4,553↓20.6% | 5,732↑2.4% | 5,600↑6.0% | 5,285 | |
| Gross Profit | 629↓0.7% | 634↓32.0% | 932↑27.1% | 733↓20.2% | 919 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 154↓31.6% | 226↑32.7% | 170↑11.2% | 153↑4.1% | 147 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 154↓31.6% | 226↑32.7% | 170↑11.2% | 153↑4.1% | 147 | |
| Other Expenses | 140↑0.6% | 139↓32.6% | 207↑16.9% | 177↑202.1% | 59 | |
| Operating Expenses | 295↓19.3% | 365↓3.1% | 377↑14.3% | 330↑60.6% | 206 | |
| Total Costs & Expenses | 5,118↑4.1% | 4,919↓19.5% | 6,109↑3.0% | 5,930↑8.0% | 5,491 | |
| Operating Results | ||||||
| Operating Income | 335↑24.7% | 268↓51.6% | 555↑37.6% | 403↓43.5% | 714 | |
| Depreciation & Amortization | 140↓31.2% | 204↓2.3% | 209↑1.4% | 206↑1.6% | 203 | |
| EBITDA | 531↑4.6% | 507↓35.8% | 790↑24.3% | 636↓34.4% | 968 | |
| EBIT | 390↑28.7% | 303↓47.8% | 581↑35.2% | 430↓43.9% | 766 | |
| Interest & Other Income | ||||||
| Net Interest Income | -118↑8.6% | -129↑35.3% | -199↓17.5% | -169↓29.5% | -131 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 5 | |
| Interest Expense | 118↓8.6% | 129↓35.3% | 199↑17.5% | 169↑24.4% | 136 | |
| Non-Operating Income | -56↓59.0% | -35↓34.2% | -26↑1.1% | -26↑49.2% | -52 | |
| Other Income / Expenses | -62↑33.9% | -94↑45.8% | -173↓20.9% | -143↓69.8% | -84 | |
| Income Before Tax | 273↑56.1% | 175↓54.3% | 382↑46.7% | 261↓58.6% | 630 | |
| Income Tax Expense | 58↑30.0% | 45↓45.8% | 83↑32.1% | 63↓51.8% | 130 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 215↑65.0% | 130↓56.6% | 300↑51.4% | 198↓60.4% | 500 | |
| Net Income from Discontinued Operations | 0.00↓100.0% | 167 | 0.00 | 0.00 | 0.00 | |
| Net Income | 146↓31.7% | 214↓12.1% | 243↑53.1% | 159↓60.5% | 402 | |
| Bottom-Line Net Income | 146↓30.9% | 212↓9.8% | 235↑53.0% | 153↓60.5% | 389 | |
| EPS (Basic) | 1.18↓28.9% | 1.66↓13.1% | 1.91↑55.3% | 1.23↓58.9% | 2.99 | |
| EPS (Diluted) | 1.18↓28.9% | 1.66↓13.1% | 1.91↑55.3% | 1.23↓58.9% | 2.99 | |
| Weighted Average Shares | 124↓4.4% | 129↑4.9% | 123↓1.2% | 125↓4.3% | 130 | |
| Weighted Average Diluted Shares | 124↓0.9% | 125↑1.2% | 123↓1.2% | 125↓4.3% | 130 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.